Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our facility produces tirzepatide with 99% purity in pharmaceutical grade quality. The white powder formulation shows greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity, making it particularly effective for metabolic research applications.
We offer flexible packaging options to meet various research requirements. Custom concentrations from 2mg to 50mg per vial are available, with options for private labeling. All batches undergo rigorous quality control testing to ensure consistency and purity.
The compound's dual mechanism of action mimics natural GIP while providing enhanced GLP-1 activity, resulting in improved glycemic control parameters. Researchers should note this product is for laboratory use only, not for human consumption.
For researchers looking to buy tirzepatide, we provide comprehensive analytical documentation including HPLC purity reports and mass spectrometry data. Our manufacturing process complies with current Good Manufacturing Practices (cGMP) for research compounds.